Company intelligence / Profile preview

Taiho Oncology

Princeton, New Jersey, United Statestaihooncology.com ↗

Ownership: Private
Employees: ~414
Development stage: Other

Overview

Taiho Oncology has successfully commercialized two orally administered chemotherapy drugs in the US—LONSURF (trifluridine/tipiracil) for metastatic colorectal/gastric cancers and INQOVI (decitabine/cedazuridine) for myelodysplastic syndromes. The company’s pipeline includes additional small molecule candidates targeting both solid tumors and hematological malignancies at various stages of clinical development. LYTGOBI (futibatinib), an FGFR inhibitor for cholangiocarcinoma, received accelerated approval from the FDA in 2022.

Therapeutic areas: Oncology
Modalities: Small molecule
Industry: Biotech

Drug pipeline

7 assets

inqovi

Approved

6 more assets in the full pipeline.

Request access →

Partnerships

Cullinan Oncology – joint development/commercialization of CLN‑081/TAS6417 EGFR inhibitor for NSCLC.Astex Pharmaceuticals – collaboration via parent Otsuka group for decitabine/cedazuridine program.

Beyond the preview

Go deeper on Taiho Oncology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Taiho Oncology.

Explore the full profile